HMMR
Basic information
Region (hg38): 5:163460203-163491941
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the HMMR gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 1 | |||||
missense | 31 | 39 | ||||
nonsense | 1 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 1 | |||||
splice region | 1 | 1 | ||||
non coding | 0 | |||||
Total | 0 | 1 | 33 | 5 | 3 |
Variants in HMMR
This is a list of pathogenic ClinVar variants found in the HMMR region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
5-163463895-T-C | not specified | Likely benign (Mar 02, 2023) | ||
5-163463900-G-T | not specified | Uncertain significance (Dec 09, 2023) | ||
5-163463934-A-G | not specified | Uncertain significance (Nov 11, 2024) | ||
5-163463949-A-T | not specified | Uncertain significance (Mar 23, 2022) | ||
5-163464744-T-A | Ovarian cancer | Benign (Jan 01, 2022) | ||
5-163464753-A-T | not specified | Uncertain significance (Mar 14, 2023) | ||
5-163467723-A-C | not specified | Uncertain significance (Apr 13, 2023) | ||
5-163469663-G-A | not specified | Uncertain significance (Feb 27, 2023) | ||
5-163469681-G-A | not specified | Uncertain significance (Oct 13, 2023) | ||
5-163469686-C-G | Familial cancer of breast | Uncertain significance (May 20, 2023) | ||
5-163469773-A-G | not specified | Uncertain significance (Oct 27, 2021) | ||
5-163469814-A-T | not specified | Uncertain significance (Sep 11, 2024) | ||
5-163469819-T-C | Ovarian cancer • not specified | Conflicting classifications of pathogenicity (Jan 16, 2024) | ||
5-163471366-A-G | not specified | Uncertain significance (Mar 20, 2024) | ||
5-163471388-T-C | not specified | Uncertain significance (Feb 27, 2023) | ||
5-163471393-A-G | not specified | Likely benign (Feb 21, 2024) | ||
5-163471423-G-A | not specified | Uncertain significance (May 14, 2024) | ||
5-163471426-G-A | not specified | Uncertain significance (Jul 26, 2022) | ||
5-163471433-A-G | not specified | Uncertain significance (Jan 26, 2023) | ||
5-163473189-G-A | not specified | Uncertain significance (Jul 05, 2024) | ||
5-163473243-G-A | not specified | Uncertain significance (Dec 11, 2023) | ||
5-163473422-C-T | Familial cancer of breast | Uncertain significance (Aug 30, 2022) | ||
5-163473482-G-A | not specified | Uncertain significance (Sep 03, 2024) | ||
5-163473558-G-T | Familial cancer of breast | Uncertain significance (Mar 20, 2019) | ||
5-163474063-A-G | not specified | Uncertain significance (Aug 13, 2021) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
HMMR | protein_coding | protein_coding | ENST00000393915 | 18 | 31739 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
5.52e-21 | 0.0209 | 124996 | 15 | 736 | 125747 | 0.00299 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.550 | 299 | 327 | 0.914 | 0.0000154 | 4774 |
Missense in Polyphen | 101 | 105.25 | 0.95963 | 1666 | ||
Synonymous | 0.815 | 109 | 120 | 0.906 | 0.00000576 | 1215 |
Loss of Function | 0.934 | 35 | 41.5 | 0.843 | 0.00000177 | 584 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00383 | 0.00376 |
Ashkenazi Jewish | 0.0552 | 0.0510 |
East Asian | 0.000451 | 0.000435 |
Finnish | 0.0000935 | 0.0000924 |
European (Non-Finnish) | 0.000980 | 0.000950 |
Middle Eastern | 0.000451 | 0.000435 |
South Asian | 0.000510 | 0.000490 |
Other | 0.00670 | 0.00621 |
dbNSFP
Source:
- Function
- FUNCTION: Receptor for hyaluronic acid (HA) (By similarity). Involved in cell motility (By similarity). When hyaluronan binds to HMMR, the phosphorylation of a number of proteins, including PTK2/FAK1 occurs. May also be involved in cellular transformation and metastasis formation, and in regulating extracellular- regulated kinase (ERK) activity. May act as a regulator of adipogenisis (By similarity). {ECO:0000250|UniProtKB:Q00547}.;
- Pathway
- ECM-receptor interaction - Homo sapiens (human);Hyaluronan uptake and degradation;Hyaluronan metabolism;Metabolism of carbohydrates;Glycosaminoglycan metabolism;Metabolism;AURKA Activation by TPX2;G2/M Transition;Mitotic G2-G2/M phases;Cell Cycle;Cell Cycle, Mitotic
(Consensus)
Recessive Scores
- pRec
- 0.276
Intolerance Scores
- loftool
- 0.998
- rvis_EVS
- 2.29
- rvis_percentile_EVS
- 98.31
Haploinsufficiency Scores
- pHI
- 0.409
- hipred
- Y
- hipred_score
- 0.566
- ghis
- 0.499
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.487
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | High |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Hmmr
- Phenotype
- reproductive system phenotype; endocrine/exocrine gland phenotype; neoplasm;
Gene ontology
- Biological process
- regulation of G2/M transition of mitotic cell cycle;hyaluronan catabolic process
- Cellular component
- centrosome;cytosol;plasma membrane;cell surface;microtubule cytoskeleton;membrane
- Molecular function
- protein binding;hyaluronic acid binding